TIDMIDEA

RNS Number : 4343O

Ideagen PLC

07 November 2016

7 November 2016

Ideagen plc

("Ideagen" or the "Company")

Trading Update

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, today provides an update on trading for the six months ended 31 October 2016.

The Board is pleased to report that trading has remained strong in the first half of the financial year.

Revenue and adjusted EBITDA are expected to show a significant increase over the same period last year through a combination of organic growth and the acquisition of Covalent. The Group expects to report organic revenue growth of approximately 16% together with a small contribution from Covalent which was acquired in August 2016. The integration of Covalent is now complete and the Company expects an increased level of contribution in the second half. Consequently, the Company continues to trade in line with market expectations for the full year to 30 April 2017.

Cash generation in the period was strong and the Company maintains a robust balance sheet with no debt. The cash balance at the period end was GBP4.8 million (30 April 2016: GBP6.3 million), after the payment of GBP3.8 million for acquisitions and associated costs.

David Hornsby, Chief Executive Officer of Ideagen, commented: "This has been a good start to the financial year. Strong trading has been driven by demand across all key vertical markets and continued momentum with our cloud-based Enlighten solution. The market opportunity remains large and long term, and consequently, the Board is optimistic about the Group's continued growth prospects."

 
 Enquiries: 
 Ideagen plc                         Tel: 01629 699100 
 David Hornsby, Chief Executive 
 Graeme Spenceley, Finance 
  Director 
 
 finnCap (Nominated Adviser          Tel: 020 7220 0500 
  and Broker) 
 Stuart Andrews / James Thompson 
  (Corporate Finance) 
 Stephen Norcross (Corporate 
  Broking) 
 
 Alma PR                             Tel: 020 8004 4218 
 Hilary Buchanan 
 Josh Royston

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.LN). Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in eGRC (Enterprise Governance, Risk and Compliance) and Healthcare solutions for organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete content lifecycle solutions that enable organisations to meet their Regulatory and Quality Compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 2,200 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTVZLFBQFFFFBQ

(END) Dow Jones Newswires

November 07, 2016 02:00 ET (07:00 GMT)

Ideagen (LSE:IDEA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ideagen Charts.
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ideagen Charts.